In this regard, earlier studies reported that Metformin inhibited proliferation in several cancer cell lines by suppressing HO-1 expression through the inhibition of a RAF/ERK/NRF2 signaling and AMPK-independent pathways that promoted a marked decrease in the NRF2 protein content [356]. This evidence concerns the gene NFE2L2 and cancer.